Unknown

Dataset Information

0

Mesenchymal stromal cell activation by breast cancer secretomes in bioengineered 3D microenvironments.


ABSTRACT: Mesenchymal stromal cells (MSCs) are key contributors of the tumour microenvironment and are known to promote cancer progression through reciprocal communication with cancer cells, but how they become activated is not fully understood. Here, we investigate how breast cancer cells from different stages of the metastatic cascade convert MSCs into tumour-associated MSCs (TA-MSCs) using unbiased, global approaches. Using mass spectrometry, we compared the secretomes of MCF-7 cells, invasive MDA-MB-231 cells, and sublines isolated from bone, lung, and brain metastases and identified ECM and exosome components associated with invasion and organ-specific metastasis. Next, we used synthetic hydrogels to investigate how these different secretomes activate MSCs in bioengineered 3D microenvironments. Using kinase activity profiling and RNA sequencing, we found that only MDA-MB-231 breast cancer secretomes convert MSCs into TA-MSCs, resulting in an immunomodulatory phenotype that was particularly prominent in response to bone-tropic cancer cells. We have investigated paracrine signalling from breast cancer cells to TA-MSCs in 3D, which may highlight new potential targets for anticancer therapy approaches aimed at targeting tumour stroma.

SUBMITTER: Blache U 

PROVIDER: S-EPMC6549139 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mesenchymal stromal cell activation by breast cancer secretomes in bioengineered 3D microenvironments.

Blache Ulrich U   Horton Edward R ER   Xia Tian T   Schoof Erwin M EM   Blicher Lene H LH   Schönenberger Angelina A   Snedeker Jess G JG   Martin Ivan I   Erler Janine T JT   Ehrbar Martin M  

Life science alliance 20190603 3


Mesenchymal stromal cells (MSCs) are key contributors of the tumour microenvironment and are known to promote cancer progression through reciprocal communication with cancer cells, but how they become activated is not fully understood. Here, we investigate how breast cancer cells from different stages of the metastatic cascade convert MSCs into tumour-associated MSCs (TA-MSCs) using unbiased, global approaches. Using mass spectrometry, we compared the secretomes of MCF-7 cells, invasive MDA-MB-2  ...[more]

Similar Datasets

2019-05-27 | PXD010467 | Pride
2019-05-28 | E-MTAB-6998 | biostudies-arrayexpress
| S-EPMC5978274 | biostudies-literature
| S-EPMC6467904 | biostudies-literature
| S-EPMC3105582 | biostudies-literature
| S-EPMC8474397 | biostudies-literature
| S-EPMC6657699 | biostudies-literature
| S-EPMC4642680 | biostudies-literature
| S-EPMC8306641 | biostudies-literature
| S-EPMC7936657 | biostudies-literature